Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct 18;2006(4):CD003727.
doi: 10.1002/14651858.CD003727.pub3.

Anticholinergics for neuroleptic-induced acute akathisia

J Rathbone  1 , K Soares-Weiser
Affiliations

Anticholinergics for neuroleptic-induced acute akathisia

J Rathbone et al. Cochrane Database Syst Rev. .

Abstract

Background: Neuroleptic-induced akathisia is one of the most common and distressing early-onset adverse effects of first generation 'typical' antipsychotic drugs. It is associated with poor compliance with treatment, and thus, ultimately, with an increased risk of relapse. We assessed the role of anticholinergic drugs as an adjunct therapy to standard antipsychotic medication in the pharmacological treatment of this adverse effect.

Objectives: To review anticholinergic drugs for neuroleptic-induced acute akathisia.

Search strategy: We searched the Cochrane Schizophrenia Group's Register (October 1999), Biological Abstracts (1982-1999), CINAHL (1982-1999), Cochrane Library (Issue 4 1999), EMBASE (1980-1999), LILACS (1982-1999), MEDLINE (1966-1999) and PsycLIT (1974-1999). References of all identified studies were inspected for more trials and we contacted first authors. Each included study was sought as a citation on the Science Citation Index database. For this 2005-6 update, we searched the Cochrane Schizophrenia Group's Register (July 2005).

Selection criteria: We included all randomised clinical trials of adjunctive anticholinergic drugs in addition to antipsychotic medication compared with placebo, for people with neuroleptic-induced acute akathisia.

Data collection and analysis: We quality assessed and extracted data independently. We calculated the fixed effects relative risk (RR), the 95% confidence intervals (CI) and, where appropriate, the number needed to treat (NNT) for homogeneous dichotomous data on an intention-to-treat basis. For continuous data, we calculated weighted mean differences (WMD).

Main results: We identified no relevant randomised controlled trials.

Authors' conclusions: At present, there is no reliable evidence to support or refute the use of anticholinergics for people suffering from neuroleptic-induced acute akathisia. Akathisia is a distressing movement disorder that remains highly prevalent in people with schizophrenia, both in the developed and developing world. This review highlights the need for well designed, conducted and reported clinical trials to address the claims of open studies as regards the effects of the anticholinergic group of drugs for akathisia.

PubMed Disclaimer

Conflict of interest statement

None.

Update of

Comment in

References

References to studies excluded from this review

Adler 1987 {published data only}
    1. Adler LA, Reiter S, Corwin J, Hemdal P, Angrist B, Rotrosen J. Differential effects of propranolol and benztropine in patients with neuroleptic‐induced akathisia. Psychopharmacology Bulletin 1987;23(3):519‐21.
Adler 1988 {published data only}
    1. Adler LA, Reiter S, Corwin J, Hemdal P, Angrist B, Rotrosen J. Neuroleptic‐induced akathisia: propranolol versus benztropine. Biological Psychiatry 1988;23:209‐14. - PubMed
Adler 1993 {published data only}
    1. Adler LA, Peselow E, Rosenthal M, Angrist B. A controlled comparison of the effects of propranolol, benztropine, and placebo on akathisia: an interim analysis. Psychopharmacology Bulletin 1993;29(2):283‐6. - PubMed
Friss 1983 {published data only}
    1. Friss T, Christensen R, Gerlach J. Sodium valproate and biperiden in neuroleptic‐induced akathisia, parkinsonism and hyperkinesia: a double‐blind, placebo, cross‐over study with placebo. Acta Psychiatrica Scandinavica 1983;67:178‐87. - PubMed
Gagrat 1978 {published data only}
    1. Gagrat D, Hamilton J, Belmaker RH. Intravenous diazepam in the treatment of neuroleptic‐induced acute dystonia and akathisia. American Journal of Psychiatry 1978;135(10):1232‐3. - PubMed
Hermesh 1988 {published data only}
    1. Hermesh H, Molcho A, Munitz H. Successful propranolol therapy for neuroleptic‐induced akathisia resistant to anticholinergic and benzodiazepine drugs. Clinical Neuropharmacology 1988;11(4):369‐72. - PubMed
Hirose 2000 {published data only}
    1. Hirose S, Ashby CR. Intravenous biperiden in akathisia: an open pilot study. International Journal of Psychiatry in Medicine 2000;30(2):185‐94. - PubMed
Horiguchi 1992 {published data only}
    1. Horiguchi J, Nishimatsu O. Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double‐blind study. Japanese Journal of Psychiatry and Neurology 1992;46(3):733‐9. - PubMed
Neu 1972 {published data only}
    1. Neu C, Demascio A, Dermigian E. Antiparkinsonian medication in the treatment of extrapyramidal side‐effects: single or multiple daily doses?. Current Therapeutic Research 1972;14(5):246‐51. - PubMed
Sachdev 1993 {published data only}
    1. Sachdev P, Loneragan C. Intravenous benztropine and propranolol challenges in acute neuroleptic‐induced akathisia. Clinical Neuropharmacology 1993;16(4):324‐31. - PubMed
    1. Sachdev P, Loneragan C. Intravenous benztropine and propranolol challenges in tardive akathisia. Psychopharmacology 1993;113:119‐22. - PubMed
Zeng 1995 {published data only}
    1. Zeng ZX, Jing LR, Liu L, Meng QL, Zhang YD. Dexetimide and benzhexolum in the treatment of drug‐induced akathisia: a double‐blind controlled trial. Chinese Journal of Pharmacoepidemiology 1995;4(2):72‐3.

Additional references

Altman 1996
    1. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200. - PMC - PubMed
Armitage 1991
    1. Armitage P. Should we cross‐off the cross‐over?. British Journal of Clinical Pharmacology 1991;32:1‐2. - PMC - PubMed
Ayd 1961
    1. Ayd FJ. A survey of drug‐induced extrapyramidal reactions. JAMA 1961;175:1054‐60. - PubMed
Barnes 1992
    1. Barnes TRE. Neuromuscular effects of neuroleptics: akathisia. In: Lieberman J, Kane JM editor(s). Adverse effects of psychotropic drugs. New York: Guilford Publications, 1992:201‐17.
Barnes 1993
    1. Barnes TRE, Edwards JG. The side effects of antipsychotic drugs. I. CNS and neuromuscular effects. Antipsychotic drugs and their side effects. London: Harcourt Brace & Company, 1993.
Bland 1997
    1. Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600. - PMC - PubMed
Braude 1983
    1. Braude WM, Barnes TRE, Gore S. Clinical characteristics of akathisia: a systematic investigation of acute psychiatric inpatient admissions. British Journal of Psychiatry 1983;143:139‐50. - PubMed
Divine 1992
    1. Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623‐9. - PubMed
Donner 2002
    1. Donner A, Klar N. Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine 2002;21:2971‐80. - PubMed
Egger 1997
    1. Egger M, Davey‐Smith G, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315:629‐34. - PMC - PubMed
Farde 1992
    1. Farde L, Norstrom AL, Halldin C. PET studies of dopamine receptors in relation to antipsychotic drug treatment. Clinical Journal of Neuropharmacology 1992;15 Supple 1 Pt ‐ A:468A‐469A. - PubMed
Grebb 1995
    1. Grebb JA. Medication induced movement disorders. In: Kaplan HI, Sadock BJ editor(s). Comprehensive textbook of psychiatry. New York: Williams & Wilkins, 1995.
Gulliford 1999
    1. Gulliford MC. Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876‐83; 876‐83. - PubMed
Halstead 1994
    1. Halstead SM, Barnes TR, Speller JC. Akathisia: prevalence and associated dysphoria in an inpatient population with chronic schizophrenia. British Journal of Psychiatry 1994;164(2):177‐83. - PubMed
Higgins 2003
    1. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327:557‐60. - PMC - PubMed
Higgins 2005
    1. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: Higgins JPT, Green S editor(s). The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd., 2005.
Jadad 1996
    1. Jadad A, Moore A, Carrol D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1‐12. - PubMed
Marder 1991
    1. Marder SR, Midha KK, Putten T, Aravagiri M, Hawes EM, Hubbard JW, et al. Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. British Journal of Clinical Psychiatry 1991;158:658‐65. - PubMed
Marshall 2000
    1. Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249‐52. - PubMed
Moher 2001
    1. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel‐group randomized trials. JAMA 2001;285:1987‐91. - PubMed
Schooler 1993
    1. Schooler NR, Keith SJ. The clinical research base for the treatment of schizophrenia. Psychopharmacology Bulletin 1993;29:431‐46. - PubMed
Schulz 1995
    1. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408‐12. - PubMed
Ukoumunne 1999
    1. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area‐wide and organisation‐based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):1‐75. - PubMed

References to other published versions of this review

Lima 2002
    1. Lima AR, Weiser KV, Bacaltchuk J, Barnes TR. Anticholinergics for neuroleptic‐induced acute akathisia. Cochrane Database Systematic Reviews 2002, Issue 3. - PubMed
Lima 2004
    1. Lima AR, Weiser KV, Bacaltchuk J, Barnes TR. Anticholinergics for neuroleptic‐induced acute akathisia. Cochrane Database Systematic Reviews 2004, Issue 1. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources